Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Piver

Showing results (51-60 of 279) with videos related to

Pageof 28
Sort By:
Gynecologic Oncology|May 1, 1995
Intestinal perforation secondary to paclitaxelP G Rose, M S Piver
European Journal of Gynaecological Oncology|May 8, 2008
The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: a personal perspectiveM S Piver, J Y Lee
Current Opinion in Obstetrics & Gynecology|December 1, 1989
NeoplasmsM S Piver, R E Hempling
Comprehensive Therapy|December 1, 1986
Potential for cure in ovarian cancerM S Piver, D L Marchetti
Obstetrics and Gynecology|March 1, 1988
Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapyM S Piver, P G Rose
Journal of Medicine|January 1, 1991
An extremely elevated serum CA125 level in a Crohn's patient developing endometriosis and the establishment of a cell line (MD-E) from the endometriomaM D Srivastava, M S Piver
American Journal of Epidemiology|November 1, 1990
A case-control study of milk-drinking and ovarian cancer riskC J Mettlin, M S Piver
Clinical Genetics|August 1, 1996
A polymorphism in intron 2 of the TP53 geneR A DiCioccio, M S Piver
Obstetrics and Gynecology|May 1, 1977
Single agent vs combination chemotherapy in the treatment of ovarian cancerJ J Barlow, M S Piver
Cancer Investigation|January 1, 1992
The genetics of ovarian cancerR A DiCioccio, M S Piver
Pageof 28

Showing results (51-60 of 279) with videos related to

Sort By:
Pageof 28
Gynecologic Oncology|May 1, 1995
Intestinal perforation secondary to paclitaxelP G Rose, M S Piver
European Journal of Gynaecological Oncology|May 8, 2008
The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: a personal perspectiveM S Piver, J Y Lee
Current Opinion in Obstetrics & Gynecology|December 1, 1989
NeoplasmsM S Piver, R E Hempling
Comprehensive Therapy|December 1, 1986
Potential for cure in ovarian cancerM S Piver, D L Marchetti
Obstetrics and Gynecology|March 1, 1988
Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapyM S Piver, P G Rose
Journal of Medicine|January 1, 1991
An extremely elevated serum CA125 level in a Crohn's patient developing endometriosis and the establishment of a cell line (MD-E) from the endometriomaM D Srivastava, M S Piver
American Journal of Epidemiology|November 1, 1990
A case-control study of milk-drinking and ovarian cancer riskC J Mettlin, M S Piver
Clinical Genetics|August 1, 1996
A polymorphism in intron 2 of the TP53 geneR A DiCioccio, M S Piver
Obstetrics and Gynecology|May 1, 1977
Single agent vs combination chemotherapy in the treatment of ovarian cancerJ J Barlow, M S Piver
Cancer Investigation|January 1, 1992
The genetics of ovarian cancerR A DiCioccio, M S Piver
Pageof 28